Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Phase II study of sitravatinib in combination with tislelizumab in patients with advanced biliary tract cancer who have failed to at least 1 prior systemic treatment: Trial in progress | JOURNAL OF CLINICAL ONCOLOGY |